Implementation of screening as a public health policy: Issues in design and evaluation

Journal of Medical Screening

Volumn 6, Issue 4, 1999, Pages 209-216

  Hakama, Matti ^a,d   Pukkala, Eero ^b   Söderman, Bengt ^b   Day, Nick ^c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Design; Effectiveness; Public health policy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; FINLAND; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFANT; MAJOR CLINICAL STUDY; METHODOLOGY; NEWBORN; PUBLIC HEALTH SERVICE;

EID: 0033396101     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.6.4.209     Document Type: Article

References (25)

1. Hakama M, Elovainio L, Kajantie R, et al. Breast cancer screening as public health policy in Finland. Br J Cancer 1991;64:962-4.
2. Pamilo M, Anttinen I, Soiva M, et al. Mammography screening - reasons for recall and the influence of experience on recall in the Finnish system. Clin Radiol 1990;41:384-7.
3. Saarenmaa I, Salminen, T, Geiger U, et al. The visibility of cancer on earlier mammograms in a population-based screening programme. Eur J Cancer 1999;35:1118-22.
4. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
5. Hakama M, Pukkala E, Heikkilä M, et al. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 1997;314: 864-7.
6. Miller AB, Chamberlain J, Day NE, et al, eds. Cancer screening. UICC project on evaluation of screening for cancer. Cambridge: International Union Against Cancer, 1991.
7. Wilson J, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organisation, 1968. (Public health paper.)
8. Zelen M, Feinleib M. On the theory of screening for chronic diseases. Biometrika 1969;56:601-14.
9. Finnish Cancer Registry. Cancer incidence in Finland 1994. Helsinki: Cancer Society of Finland, 1996: No 57.
10. Shapiro S, Venet W, Strax P, et al. Current results of the breast cancer screening randomized trial: the Health Insurance Plan (HIP) of Greater New York Study. In: Day NE, Miller AB, eds. Screening for breast cancer. Bern: Hans Huber, 1988:3-15.
11. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: over-view of Swedish randomised trials. Lancet 1993;341:973-8.
12. Hakama M, Hakulinen T. Estimating the expectation of life in cancer survival studies with incomplete follow-up information. Journal of Chronic Diseases 1977;30:585-97.
13. Pukkala E, Sankila R, Vertio H. Syöpä suomessa. Helsinki: Suomen Syöpärekisteri, 1997.
14. Quinn M, Allen E, on behalf of the United Kingdom Association of Cancer Registries. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ 1995;311:1391-5.
15. The Gambia Hepatitis Study Group. The Gambia Hepatitis Intervention Study. Cancer Res 1987;47:5782-7.
16. Hakama M, Räsänen-Virtanen U. Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol 1976;103:512-17.
17. 16a Wilmink TB, Quick CR, Hubbard CS, et al. The influence of screening on the incidence of ruptured aortic aneurysms. J Vasc Surg 1999;30:203-8.
18. Tabár L, Fagerberg G, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;i:829-32.
19. Tabár L, Fagerberg G, Duffy SW, et al. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989;43:107-14.
20. UK Trial of Early Detection of Breast Cancer Group. Breast cancer mortality after 10 years in the UK trial of early detection of breast cancer. Breast 1993;2:13-20.
21. Wright CJ, Mueller CB. Screening mammography and public health policy: the need for perspective. Lancet 1995;346: 29-32.
22. de Koning HJ, van Ineveld BM, van Oortmarssen GJ, et al. Breast cancer screening and cost effectiveness; policy alternatives, quality of life considerations and possible impact of uncertain factors. Int J Cancer 1991;49:531-7.
23. Hristova L, Hakama M. Effect of screening for cancer in the Nordic countries on deaths, costs and quality of life up to the year 2017. Acta Oncol 1997;36(suppl 9): 1-60.
24. McGee M, Brayne C. The impact on prevalence of dementia in the oldest age groups of differential mortality patterns: a deterministic approach. Int J Epidemiol 1998;27: 87-90.
25. Habbema JDF, van der Heide A, van den Bosch JMH, et al. Cost-effectiveness considerations in chemoprevention of cancer. In: Hakama M, Beral V, Buiatti E, et al, eds. Chemoprevention in cancer control. Lyon: IARC Scientific Publications, 1996; No 136:131-8.